Skip to content
Screener

Prestige Consumer Healthcare PBH Common Stock Par Value Per Share

Common Stock Par Value Per Share at other companies

Perrigo Company logo
Perrigo CompanyPRGO
$0.000.0%
HRO
HarrowHROW
$0.000.0%
Organon logo
OrganonOGN
$0.010.0%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$0.00
Kenvue logo
KenvueKVUE
$0.010.0%
Helen Of Troy logo
Helen Of TroyHELE
$0.100.0%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)June 30, 2026March 31, 2026
Preferred stock - $0.01 par value
Authorized - 5,000 shares
Issued and outstanding - None
Common stock - $0.01 par value
Authorized - 250,000 shares
Issued - 56,312 shares at June 30, 2026 and 56,211 shares at March 31, 2026563562
Additional paid-in capital612,513608,520
Treasury stock, at cost - 8,940 shares at June 30, 2026 and 8,892 shares at March 31, 2026(441,962)(439,301)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's common stock par value per share?
Prestige Consumer Healthcare (PBH) reported common stock par value per share of $0.01 in Q2 2026.
How has Prestige Consumer Healthcare's common stock par value per share changed year-over-year?
Prestige Consumer Healthcare's common stock par value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for Prestige Consumer Healthcare's common stock par value per share?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
What does common stock par value per share mean?
The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.

Ask your AI about Prestige Consumer Healthcare's common stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude